Journal of Cancer Research and Therapeutics Close
 

Figure 2: Boxplot chart showing imatinib levels at 12 months in patients who had molecular response (BCR-ABL by RQ-PCR) ?1% or >1%

Figure 2: Boxplot chart showing imatinib levels at 12 months in patients who had molecular response (BCR-ABL by RQ-PCR) ?1% or >1%